

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 10mg | 360 pills | C$1.49 | C$668.73 C$534.99 Best Price | |
| 10mg | 180 pills | C$1.57 | C$351.32 C$281.05 | |
| 10mg | 120 pills | C$1.59 | C$239.86 C$191.88 | |
| 10mg | 90 pills | C$1.67 | C$186.55 C$149.24 | |
| 10mg | 60 pills | C$1.74 | C$130.82 C$104.66 | |
| 10mg | 30 pills | C$2.00 | C$75.09 C$60.07 | |
| 20mg | 360 pills | C$2.23 | C$1,005.53 C$804.43 | |
| 20mg | 240 pills | C$2.27 | C$680.85 C$544.68 | |
| 20mg | 180 pills | C$2.29 | C$516.08 C$412.87 | |
| 20mg | 120 pills | C$2.33 | C$348.89 C$279.11 | |
| 20mg | 90 pills | C$2.38 | C$268.93 C$215.15 | |
| 20mg | 60 pills | C$2.42 | C$184.13 C$147.30 | |
| 20mg | 30 pills | C$2.48 | C$94.47 C$75.58 | |
| 30mg | 240 pills | C$3.43 | C$1,029.76 C$823.81 | |
| 30mg | 180 pills | C$3.47 | C$780.19 C$624.15 | |
| 30mg | 120 pills | C$3.51 | C$525.77 C$420.62 | |
| 30mg | 90 pills | C$3.55 | C$399.78 C$319.82 | |
| 30mg | 60 pills | C$3.62 | C$271.36 C$217.08 | |
| 30mg | 30 pills | C$3.88 | C$145.36 C$116.29 | |
| 40mg | 180 pills | C$4.59 | C$1,032.19 C$825.75 Popular | |
| 40mg | 120 pills | C$4.75 | C$712.35 C$569.88 | |
| 40mg | 90 pills | C$4.79 | C$537.89 C$430.31 | |
| 40mg | 60 pills | C$4.85 | C$363.43 C$290.74 | |
| 40mg | 30 pills | C$5.04 | C$188.97 C$151.18 |
Disclaimer: This information is for educational purposes and is not a substitute for professional medical advice. For medical concerns, consult a healthcare professional.
Paxil is paroxetine, an SSRI (selective serotonin reuptake inhibitor) used to treat major depressive disorder and anxiety disorders.
It is categorized as an SSRI, a mechanism that increases serotonin levels in the brain to improve mood and reduce anxiety symptoms.
The primary therapeutic aim is to reduce depressive symptoms and alleviate anxiety, helping to restore normal daily functioning.
In Canada, Paxil is typically prescribed by a clinician after careful assessment of the patient’s condition and treatment history.
Paxil is available in tablet formulations and may be supplied as generic paroxetine in addition to brand-name Paxil, depending on supply and provincial regulations.
Paxil is used to treat mood and anxiety disorders in adults and, in some cases, in adolescents under clinician supervision. The medication may be considered when symptoms significantly impair functioning or when other therapies have not provided sufficient relief.
When choosing between Paxil and alternatives, clinicians assess the patient’s symptom profile, past responses to treatment, and coexisting medical or psychiatric conditions. Tolerability, potential drug interactions, and pregnancy considerations influence the decision.
Response timelines are variable; some benefit may be observed within the first few weeks, with a substantial improvement often emerging after several weeks of consistent use. Continued evaluation by a clinician is essential to determine ongoing suitability.
Alternative strategies may include other SSRIs or non-SSRI antidepressants, cognitive-behavioral therapy, or a combination of therapy and pharmacotherapy. The choice depends on how the condition presents and how well tolerability is managed.
It should be noted that individual experiences with Paxil can diverge from those with other medications in the same class. Check the official leaflet and consult a healthcare professional for personalized guidance on indications and alternatives.
Paroxetine functions by inhibiting the reuptake of serotonin at the synaptic cleft, increasing serotonin signaling in brain circuits involved in mood regulation.
Compared with some other SSRIs, paroxetine has relatively higher anticholinergic activity, which can influence certain side effects such as dry mouth, constipation, and urinary retention in susceptible individuals.
The half-life of paroxetine is relatively shorter than that of many其他 SSRIs, which can contribute to withdrawal symptoms if discontinuation occurs abruptly or without a taper. Clinical practice emphasizes gradual dose changes under supervision.
Pharmacokinetic interactions with liver function and age may modify exposure to the drug, and adherence to prescribed dosing helps maintain stable plasma levels and therapeutic effect.
Direct comparisons with common antidepressants are provided to inform treatment decisions in collaboration with a healthcare professional. Different medications offer similar therapeutic goals but differ in onset, tolerability, and side-effect profiles.
Below is a concise tabular comparison to illustrate general differences in the context of typical clinical use. Individual responses vary and definitive choices should be guided by a clinician.
Consult the official product information or a healthcare professional for personalized advice before making changes to therapy.
| Name | Primary Use | Typical Onset | Key Advantage |
|---|---|---|---|
| Paxil (paroxetine) | Mood and anxiety disorders, including depressive symptoms and certain anxiety conditions | Initial improvements may be seen within 2–4 weeks; full benefit often by 6–8 weeks | Noted efficacy for a range of anxiety disorders; relatively familiar prescribing pattern in many practice settings |
| Fluoxetine (Prozac) | Major depressive disorder and various anxiety disorders; chronic fatigue in some cases | Often takes several weeks for full effect | Long half-life, which may reduce withdrawal risk after stopping; activating (stimulant-like) properties can help some patients |
| Sertraline (Zoloft) | Depression and multiple anxiety disorders | Typically 4–6 weeks for noticeable benefit | Broad efficacy across conditions; generally well tolerated in many patients |
| Escitalopram (Lexapro/Cipralex) | Depression and generalized anxiety disorder | Often 1–4 weeks for initial improvement | Often well tolerated with a predictable response profile |
Careful adherence to a clinician’s dosing instructions is essential. The prescribed regimen should be followed exactly as directed, and any questions regarding dosing must be addressed with a healthcare professional.
Formulations include conventional immediate-release tablets and extended-release versions; the chosen form is determined by the clinician based on patient needs and tolerability. Changes in formulation should occur under supervision to maintain stability of symptoms.
Medication timing can influence tolerability and effectiveness. The same daily time is often recommended to maintain stable drug levels, and consistency with meals is not universally required but may be advised.
Missed doses warrant consultation with a clinician or pharmacist for guidance. In some cases, the dose may be resumed at the next scheduled time rather than compensating with a double dose, depending on the dose and timing of the missed dose.
Storage should be at room temperature, away from moisture and heat. Keep medications out of reach of others, especially children, to prevent accidental ingestion or misuse.
Common adverse effects may include nausea, headaches, sleep disturbances, and sexual side effects. These symptoms frequently diminish over time as the body adjusts to therapy, but persistent or severe effects warrant medical review.
Serious warnings include the potential for increased suicidal thoughts or behavior in some youths and young adults starting antidepressant therapy. If thoughts of harming oneself arise, prompt medical attention is required.
Contraindications include known hypersensitivity to paroxetine or any excipients in the formulation. Concomitant use with certain medicines may be unsafe and requires professional guidance.
Precautions focus on the risk of serotonin syndrome when combined with other serotonergic agents, interactions with monoamine oxidase inhibitors (MAOIs), and the potential for hyponatremia in susceptible individuals, particularly older adults. A clinician should assess all health factors prior to initiation.
Pregnancy and breastfeeding require careful risk-benefit discussion with a clinician. The potential impact on fetal development or infant exposure must be weighed against clinical need and alternative therapies. Seek guidance before starting or continuing Paxil during pregnancy or lactation.
Significant drug interactions include combinations with MAO inhibitors, which can cause serious adverse effects. A careful review of all medications is required before starting Paxil.
Concurrent use with other serotonergic drugs or with antiplatelet or anticoagulant therapies may increase the risk of bleeding or serotonin-related adverse effects. Clinicians may monitor for signs of adverse effects or bleeding tendencies if such combinations are unavoidable.
Certain medications that influence liver metabolism or interact with CYP enzymes can alter Paxil exposure. Dose adjustments or alternative therapies may be considered in these scenarios.
Alcohol consumption should be discussed with a clinician, as it can affect mood, sleep, and the risk of certain adverse effects during Paxil therapy. Generally, alcohol use is advised to be limited or avoided while taking antidepressants unless otherwise directed.
Individuals with a history of manic episodes, bipolar spectrum disorders, or other psychiatric conditions should disclose this information to a clinician, as treatment choices may differ to reduce risk and optimize outcomes.
In older adults, careful monitoring for hyponatremia, falls, and cognitive changes is advised, as the elderly may have increased sensitivity to certain adverse effects.
Renal or hepatic impairment may necessitate dose adjustments or closer clinical supervision. The degree of impairment determines the approach taken by the prescriber.
In pediatric and adolescent patients, monitoring for mood changes, suicidality, and behavior alterations is essential during initiation and dose changes. Family education and caregiver involvement support safety and effectiveness.
Pregnancy and lactation require individualized risk assessments. If pregnancy is planned or confirmed, discuss potential benefits and risks with a clinician before continuing or initiating Paxil.
Ethical and cultural considerations, along with local formulary status, influence prescribing practices in Canada. Seek guidance from a pharmacist or clinician regarding availability and suitability within the relevant jurisdiction.
Paxil is used for several anxiety-related conditions, though the suitability for a specific disorder depends on clinical assessment and regulatory approvals. Consultation with a clinician is advised to determine appropriateness.
Comparative effectiveness varies by individual and condition. A clinician will consider symptom profile, prior responses, and tolerability to determine whether Paxil is a suitable option or if another SSRI may be preferred.
Abrupt discontinuation may lead to withdrawal-like symptoms or a rebound of symptoms. A gradual taper under professional supervision is typically recommended to minimize these effects.
Medication switching is possible under medical supervision. A clinician will plan a taper or overlap strategy to reduce withdrawal risks and ensure continued symptom control.
Pregnancy involves weighing potential risks to the fetus against the benefits of treating maternal conditions. A clinician will discuss options, including potential alternatives, before continuing Paxil during pregnancy.
Generic paroxetine is commonly available in many regions, depending on supply and regulatory status. A pharmacist can confirm current availability in a specific location.
Choice depends on the individual’s symptom pattern, past responses to treatment, comorbid conditions, and tolerability. Some patients may respond better or experience fewer side effects with one medication than another.
Therapeutic response is typically evaluated over several weeks. A clinician will determine whether continuation or adjustment is appropriate based on symptom changes and tolerability.
Some individuals may experience dry mouth, constipation, sedation, or weight changes more than with other SSRIs. Side effects often diminish with time, but persistent concerns should be discussed with a clinician.
Some supplements may interact with Paxil or alter mood and agitation. Disclosure of all substances to a clinician or pharmacist is essential for safe management.
Use in older adults requires careful assessment for comorbidities and potential adverse effects. Dosing and monitoring plans are tailored to the individual risk profile.
Sleep disturbances may respond to timing adjustments, dose modifications, or alternative treatments. A clinician can propose strategies to improve sleep while maintaining mood stabilization.
Interactions with anticoagulants or nonsteroidal anti-inflammatory drugs may affect bleeding risk. A clinician may adjust therapy or implement monitoring if such combinations are necessary.
Inconsistent dosing may reduce efficacy and increase withdrawal risk. A healthcare professional will provide guidance on resuming therapy safely and maintaining consistency.
For comprehensive information, consult the official patient information leaflet supplied with the medication and speak with a pharmacist or clinician. Leaflets provide details on indications, contraindications, and specific cautions related to the product available in the relevant region.
Healthcare professionals can tailor information to individual circumstances, including age, pregnancy status, liver function, and concomitant medications. Seek advice before making changes to therapy or discontinuing Paxil.
Online pharmacy resources should complement professional care and are not a substitute for in-person assessment. Use information from reputable sources and verify with a clinician for medical decisions.
In case of severe symptoms, acute distress, or suspected adverse reactions, seek urgent medical help and contact a clinician promptly. If unsure about any information in this leaflet, check the official leaflets or ask a pharmacist for clarification.
14–21 days. Free from C$276.92 .
5–9 days. C$41.54
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
